The lack of success in drug trials has a negative impact on the Foster City company's China strategy and stock price. Apollomics Inc., a late-stage clinical biopharmaceutical company, said its ...
This follows the Central Licensing Authority (CLA) recently allowing a local clinical trial waiver during the approval process for five categories of new drugs, sourced from six countries.